Alytas Therapeutics
Pre-clinicalalytas therapeutics GmbH is a spin-off of the University Hospital Jena with the mission to develop novel antibody-based therapeutic concepts for the treatment of morbid obesity (adiposity). Obesity is one of the greatest risk factors for human health and mental well-being in the 21st century (Robert Koch Institute).
Founded
1975
Focus
AntibodiesBiologics
About
alytas therapeutics GmbH is a spin-off of the University Hospital Jena with the mission to develop novel antibody-based therapeutic concepts for the treatment of morbid obesity (adiposity). Obesity is one of the greatest risk factors for human health and mental well-being in the 21st century (Robert Koch Institute).
Company Info
TypePrivate
Founded1975
LocationMunich, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile